Fig. 4

Duration of treatment outcomes by index treatment. Kaplan-Meier analysis of the duration of treatment outcomes in patients with ulcerative colitis (panels a-c) or Crohn’s disease (panels d-f) by index treatment (vedolizumab vs anti-tumor necrosis factor alpha [anti-TNFα])